The epidemiology of lower extremity amputations, strategies for amputation prevention, and the importance of patient-centered care

被引：26
作者：
Bernatchez, Julien [1 ]
Mayo, Amanda [2 ]
Kayssi, Ahmed [1 ]
机构：
[1] Univ Toronto, Div Vasc Surg, Toronto, ON, Canada
[2] Univ Toronto, Div Phys Med & Rehabil, Toronto, ON, Canada
来源：
SEMINARS IN VASCULAR SURGERY | 2021年 / 34卷 / 01期
关键词：
PERIPHERAL ARTERIAL-DISEASE; DIABETIC FOOT; VASCULAR-SURGERY; MANAGEMENT; SOCIETY; TRENDS; COMPLICATIONS; DISPARITIES; MORTALITY; ISCHEMIA;
D O I：
10.1053/j.semvascsurg.2021.02.011
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Dysvascular amputations, defined as those secondary to the complications of peripheral arterial disease or diabetes mellitus, are the most common cause of lower extremity amputations. Despite recent advancements in diabetes mellitus treatments and the many modern innovations in endovascular therapies, the incidence of dysvascular lower ex-tremity amputations has not improved. In this article, we will review the most recent epidemiological data on lower extremity amputations, discuss the latest recommenda-tions from different medical societies for the prevention of limb loss, and explore the role of the vascular surgeon as part of a multidisciplinary team in providing comprehensive care for patients at risk of undergoing amputations for ischemic or diabetic complications. We will also discuss the importance of considering patient perspectives and patient-reported outcomes to better understand the impact of amputations on the patient experience. ? 2021 Published by Elsevier Inc.
引用
收藏
页码：54 / 58
页数：5
相关论文
共 42 条
  • [1] The Epidemiology of Amputation Inequality Extends Beyond Diabetes in England
    Ahmad, Naseer
    Adderley, Una
    Ionac, Mihai
    Bowling, Frank L.
    [J]. INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2019, 18 (02) : 112 - 113
  • [2] A systematic review for the screening for peripheral arterial disease in asymptomatic patients
    Alahdab, Fares
    Wang, Amy T.
    Elraiyah, Tarig A.
    Malgor, Rafael D.
    Rizvi, Adnan Z.
    Lane, Melanie A.
    Prokop, Larry J.
    Montori, Victor M.
    Conte, Michael S.
    Murad, Mohammad Hassan
    [J]. JOURNAL OF VASCULAR SURGERY, 2015, 61 (03) : 42S - 53S
  • [3] Standards of medical care in diabetes 2008
    不详
    [J]. DIABETES CARE, 2008, 31 : S12 - S54
  • [4] Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
    Anand, Sonia S.
    Bosch, Jackie
    Eikelboom, John W.
    Connolly, Stuart J.
    Diaz, Rafael
    Widimsky, Peter
    Aboyans, Victor
    Alings, Marco
    Kakkar, Ajay K.
    Keltai, Katalin
    Maggioni, Aldo P.
    Lewis, Basil S.
    Stoerk, Stefan
    Zhu, Jun
    Lopez-Jaramillo, Patricio
    O'Donnell, Martin
    Commerford, Patrick J.
    Vinereanu, Dragos
    Pogosova, Nana
    Ryden, Lars
    Fox, Keith A. A.
    Bhatt, Deepak L.
    Misselwitz, Frank
    Varigos, John D.
    Vanassche, Thomas
    Avezum, Alvaro A.
    Chen, Edmond
    Branch, Kelley
    Leong, Darryl P.
    Bangdiwala, Shrikant I.
    Hart, Robert G.
    Yusuf, Salim
    [J]. LANCET, 2018, 391 (10117) : 219 - 229
  • [5] Diabetic Foot Ulcers and Their Recurrence
    Armstrong, David G.
    Boulton, Andrew J. M.
    Bus, Sicco A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (24) : 2367 - 2375
  • [6] Barshes Neal R, 2018, Tex Public Health J, V70, P22
  • [7] Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial
    Berger, Jeffrey S.
    Abramson, Beth L.
    Lopes, Renato D.
    Heizer, Gretchen
    Rockhold, Frank W.
    Baumgartner, Iris
    Fowkes, F. Gerry R.
    Held, Peter
    Katona, Brian G.
    Norgren, Lars
    Jones, W. Schuyler
    Millegard, Marcus
    Blomster, Juuso
    Reist, Craig
    Hiatt, William R.
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    [J]. VASCULAR MEDICINE, 2018, 23 (06) : 523 - 530
  • [8] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Bhatt, DL
    Fox, KAA
    Hacke, W
    Berger, PB
    Black, HR
    Boden, WE
    Cacoub, P
    Cohen, EA
    Creager, MA
    Easton, JD
    Flather, MD
    Haffner, SM
    Hamm, CW
    Hankey, GJ
    Johnston, SC
    Mak, KH
    Mas, JL
    Montalescot, G
    Pearson, TA
    Steg, PG
    Steinhubl, SR
    Weber, MA
    Brennan, DM
    Fabry-Ribaudo, L
    Booth, J
    Topol, EJ
    Frye, RL
    Amarenco, P
    Brass, LM
    Buyse, M
    Cohen, LS
    DeMets, DL
    Fuster, V
    Hart, RG
    Marler, JR
    McCarthy, C
    Schoemig, A
    Lincoff, AM
    Brener, SJ
    Sila, CA
    Albuquerque, A
    Aroutiounov, G
    Artemiev, D
    Atkeson, BG
    Bartel, T
    Basart, DCG
    Lima, AB
    Belli, G
    Bordalo e Sa, AL
    Bosch, X
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) : 1706 - 1717
  • [9] Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 4: patient-reported outcomes can inform clinical decision making in chronic care
    Bingham, Clifton O., III
    Noonan, Vanessa K.
    Auger, Claudine
    Feldman, Debbie E.
    Ahmed, Sara
    Bartlett, Susan J.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 89 : 136 - 141
  • [10] Rivaroxaban in Peripheral Artery Disease after Revascularization
    Bonaca, Marc P.
    Bauersachs, Rupert M.
    Anand, Sonia S.
    Debus, E. Sebastian
    Nehler, Mark R.
    Patel, Manesh R.
    Fanelli, Fabrizio
    Capell, Warren H.
    Diao, Lihong
    Jaeger, Nicole
    Hess, Connie N.
    Pap, Akos F.
    Kittelson, John M.
    Gudz, Ivan
    Matyas, Lajos
    Krievins, Dainis K.
    Diaz, Rafael
    Brodmann, Marianne
    Muehlhofer, Eva
    Haskell, Lloyd P.
    Berkowitz, Scott D.
    Hiatt, William R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21) : 1994 - 2004
12345